Corgenix Medical Corp. has successfully completed the feasibility stage for a new, high-speed automated test format for its AspirinWorks Test, developed in collaboration with Randox Laboratories. The new format was created to make it faster and easier to perform the AspirinWorks Test at clinical labs and hospitals. “We’ve taken another critical step forward in expanding the potential market for the AspirinWorks Test,” said Douglass Simpson, Corgenix president and chief executive. “The next s...